TOP 100 WEIGHT LOSS SITES
| |||
|
| |||
| |||
|
| |||
| Periods Of Excessive And Rapid Weight Loss May Be Associated With Internal Hernia After Bariatric Surgery For the first time, surgeons have linked internal hernia with excessive and rapid weight loss after undergoing minimally invasive surgical treatment of morbid obesity. (Internal hernia is a defect in the abdominal cavity that allows abdominal structures, such as the intestines, to move out of their natural position. However, the condition can be corrected surgically before it leads to potentially serious bowel obstruction. medicalnewstoday.com |
Anti-Obesity Treatment In Pharmacies Offers Convenient And Effective Care For Patients The availability of anti-obesity drug Orlistat from pharmacies provides accessible and convenient care for patients, said the Royal Pharmaceutical Society of Great Britain (RPSGB). David Pruce, RPSGB Director of Policy and Communications said: "We fully support the move to make Orlistat available in pharmacies without prescription. Pharmacists' roles are changing and this is great opportunity to make a real impact on improving patients' health. medicalnewstoday.com |
Discovery Of Cancer-Obesity Link By MSU Researchers Could Aid Prevention Efforts A new link between body fat and cancer identified by a Michigan State University researcher underscores obesity's health risk and could lead to new cancer treatment and prevention strategies. Jenifer Fenton, an MSU food science and human nutrition researcher with the Michigan Agricultural Experiment Station, identified the connection between obesity and colon cancer, the third-leading killer of Americans, in part by examining tissue hormones. medicalnewstoday.com |
Low Short-Term Risks After Bariatric Surgery For Extreme Obesity: NIH Study Short-term complications and death rates were low following bariatric surgery to limit the amount of food that can enter the stomach, decrease absorption of food or both, according to the Longitudinal Assessment of Bariatric Surgery (LABS-1). The study was funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health. Results are reported in the July 30 issue of the New England Journal of Medicine. medicalnewstoday.com |
GI Dynamics' EndoBarrier ™ Gastrointestinal Liner Demonstrates Significant HbA1c Reduction In Obese People Living With Type 2 Diabetes GI Dynamics, a leader in non-surgical treatments for type 2 diabetes and obesity, today announced data which demonstrate that obese patients with uncontrolled type 2 diabetes using the EndoBarrier™ Gastrointestinal Liner achieved near normalization of glycemic control in just one week, as compared to a sham control group. In addition, patients treated with EndoBarrier achieved a mean reduction of 2.4% in HbA1c glucose levels versus 0.8% for the sham arm at 24 weeks. medicalnewstoday.com |